Report Detail
Global Vinblastinesulphate (CAS 143-67-9) Market Insights, Forecast to 2025
- RnM2470906 |
- 30 April, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Other
Vinblastinesulphate is a white or light yellow amorphous power, which is easily soluble in water. Vinblastine belongs to the group of cancer-fighting medications known as antineoplastics. Vinblastine is used alone or in combination with other antineoplastic medications to treat many different types of cancer including Hodgkin's disease, non-Hodgkin's lymphoma (cancer of the lymph cells), Kaposi's sarcoma, breast cancer, and testicular cancer. It kills cancer cells by interfering with the genetic material DNA, which is necessary for their growth and reproduction.
Periwinkle Plantation is mainly concentrated in China. The production volume was high during 2000s, with a kilo of Vinca alkaloids can be sold at 10 USD/gram. Now as the less plantation in Hainan Province, the cost of Periwinkle and Vinca alkaloids has hiked at 20 USD/ gram. Currenly there are less companies produce Vinca alkaloids, since many companies couldn’t survive after capital chain breaks. Globally, leading suppliers are Guangzhou Hanfang Pharmaceutical, Hainan Vinca Biological Medicine Technology and Guangzhou Person Pharmaceutical which are located in China. The three companies produced nealy 60% of global Vinblastinesulphate Vinkem from India also produce Vinblastinesulphate API for cancer treatment drugs.
Global Vinblastinesulphate (CAS 143-67-9) market size will increase to 21 Million US$ by 2025, from 19 Million US$ in 2018, at a CAGR of 1.1% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Vinblastinesulphate (CAS 143-67-9).
This report researches the worldwide Vinblastinesulphate (CAS 143-67-9) market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global Vinblastinesulphate (CAS 143-67-9) breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
The following manufacturers are covered in this report:
Guangzhou Hanfang Pharmaceutical
Hainan Vinca Biological Medicine Technology
Guangzhou Person Pharmaceutical
Hainan Yueyang Biotechnology
Hubei Honch Pharmaceutical
Fine Chemicals Corporation
Hengtengfu Biological Products
Vinkem
Vinblastinesulphate (CAS 143-67-9) Breakdown Data by Type
>98% Vinblastinesulphate
97-98% Vinblastinesulphate
Other
Vinblastinesulphate (CAS 143-67-9) Breakdown Data by Application
Lymphoma
Lung Cancer
Breast & Ovarian Cancer
Leukemia
Other
Vinblastinesulphate (CAS 143-67-9) Production Breakdown Data by Region
United States
Europe
China
Japan
Other Regions
Vinblastinesulphate (CAS 143-67-9) Consumption Breakdown Data by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa
The study objectives are:
To analyze and research the global Vinblastinesulphate (CAS 143-67-9) capacity, production, value, consumption, status and forecast;
To focus on the key Vinblastinesulphate (CAS 143-67-9) manufacturers and study the capacity, production, value, market share and development plans in next few years.
To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Vinblastinesulphate (CAS 143-67-9) :
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
Global Vinblastinesulphate (CAS 143-67-9) Market Research Report 2019-2025, by Manufacturers, Regions, Types and Applications
1 Study Coverage
- 1.1 Vinblastinesulphate (CAS 143-67-9) Product
- 1.2 Key Market Segments in This Study
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Vinblastinesulphate (CAS 143-67-9) Market Size Growth Rate by Type
- 1.4.2 >98% Vinblastinesulphate
- 1.4.3 97-98% Vinblastinesulphate
- 1.4.4 Other
- 1.5 Market by Application
- 1.5.1 Global Vinblastinesulphate (CAS 143-67-9) Market Size Growth Rate by Application
- 1.5.2 Lymphoma
- 1.5.3 Lung Cancer
- 1.5.4 Breast & Ovarian Cancer
- 1.5.5 Leukemia
- 1.5.6 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Vinblastinesulphate (CAS 143-67-9) Production
- 2.1.1 Global Vinblastinesulphate (CAS 143-67-9) Revenue 2014-2025
- 2.1.2 Global Vinblastinesulphate (CAS 143-67-9) Production 2014-2025
- 2.1.3 Global Vinblastinesulphate (CAS 143-67-9) Capacity 2014-2025
- 2.1.4 Global Vinblastinesulphate (CAS 143-67-9) Marketing Pricing and Trends
- 2.2 Vinblastinesulphate (CAS 143-67-9) Growth Rate (CAGR) 2019-2025
- 2.3 Analysis of Competitive Landscape
- 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 2.3.2 Key Vinblastinesulphate (CAS 143-67-9) Manufacturers
- 2.4 Market Drivers, Trends and Issues
- 2.5 Macroscopic Indicator
- 2.5.1 GDP for Major Regions
- 2.5.2 Price of Raw Materials in Dollars: Evolution
3 Market Size by Manufacturers
- 3.1 Vinblastinesulphate (CAS 143-67-9) Production by Manufacturers
- 3.1.1 Vinblastinesulphate (CAS 143-67-9) Production by Manufacturers
- 3.1.2 Vinblastinesulphate (CAS 143-67-9) Production Market Share by Manufacturers
- 3.2 Vinblastinesulphate (CAS 143-67-9) Revenue by Manufacturers
- 3.2.1 Vinblastinesulphate (CAS 143-67-9) Revenue by Manufacturers (2014-2019)
- 3.2.2 Vinblastinesulphate (CAS 143-67-9) Revenue Share by Manufacturers (2014-2019)
- 3.3 Vinblastinesulphate (CAS 143-67-9) Price by Manufacturers
- 3.4 Mergers & Acquisitions, Expansion Plans
4 Vinblastinesulphate (CAS 143-67-9) Production by Regions
- 4.1 Global Vinblastinesulphate (CAS 143-67-9) Production by Regions
- 4.1.1 Global Vinblastinesulphate (CAS 143-67-9) Production Market Share by Regions
- 4.1.2 Global Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Regions
- 4.2 United States
- 4.2.1 United States Vinblastinesulphate (CAS 143-67-9) Production
- 4.2.2 United States Vinblastinesulphate (CAS 143-67-9) Revenue
- 4.2.3 Key Players in United States
- 4.2.4 United States Vinblastinesulphate (CAS 143-67-9) Import & Export
- 4.3 Europe
- 4.3.1 Europe Vinblastinesulphate (CAS 143-67-9) Production
- 4.3.2 Europe Vinblastinesulphate (CAS 143-67-9) Revenue
- 4.3.3 Key Players in Europe
- 4.3.4 Europe Vinblastinesulphate (CAS 143-67-9) Import & Export
- 4.4 China
- 4.4.1 China Vinblastinesulphate (CAS 143-67-9) Production
- 4.4.2 China Vinblastinesulphate (CAS 143-67-9) Revenue
- 4.4.3 Key Players in China
- 4.4.4 China Vinblastinesulphate (CAS 143-67-9) Import & Export
- 4.5 Japan
- 4.5.1 Japan Vinblastinesulphate (CAS 143-67-9) Production
- 4.5.2 Japan Vinblastinesulphate (CAS 143-67-9) Revenue
- 4.5.3 Key Players in Japan
- 4.5.4 Japan Vinblastinesulphate (CAS 143-67-9) Import & Export
- 4.6 Other Regions
- 4.6.1 South Korea
- 4.6.2 India
- 4.6.3 Southeast Asia
5 Vinblastinesulphate (CAS 143-67-9) Consumption by Regions
- 5.1 Global Vinblastinesulphate (CAS 143-67-9) Consumption by Regions
- 5.1.1 Global Vinblastinesulphate (CAS 143-67-9) Consumption by Regions
- 5.1.2 Global Vinblastinesulphate (CAS 143-67-9) Consumption Market Share by Regions
- 5.2 North America
- 5.2.1 North America Vinblastinesulphate (CAS 143-67-9) Consumption by Application
- 5.2.2 North America Vinblastinesulphate (CAS 143-67-9) Consumption by Countries
- 5.2.3 United States
- 5.2.4 Canada
- 5.2.5 Mexico
- 5.3 Europe
- 5.3.1 Europe Vinblastinesulphate (CAS 143-67-9) Consumption by Application
- 5.3.2 Europe Vinblastinesulphate (CAS 143-67-9) Consumption by Countries
- 5.3.3 Germany
- 5.3.4 France
- 5.3.5 UK
- 5.3.6 Italy
- 5.3.7 Russia
- 5.4 Asia Pacific
- 5.4.1 Asia Pacific Vinblastinesulphate (CAS 143-67-9) Consumption by Application
- 5.4.2 Asia Pacific Vinblastinesulphate (CAS 143-67-9) Consumption by Countries
- 5.4.3 China
- 5.4.4 Japan
- 5.4.5 South Korea
- 5.4.6 India
- 5.4.7 Australia
- 5.4.8 Indonesia
- 5.4.9 Thailand
- 5.4.10 Malaysia
- 5.4.11 Philippines
- 5.4.12 Vietnam
- 5.5 Central & South America
- 5.5.1 Central & South America Vinblastinesulphate (CAS 143-67-9) Consumption by Application
- 5.5.2 Central & South America Vinblastinesulphate (CAS 143-67-9) Consumption by Countries
- 5.5.3 Brazil
- 5.6 Middle East and Africa
- 5.6.1 Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Consumption by Application
- 5.6.2 Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Consumption by Countries
- 5.6.3 Turkey
- 5.6.4 GCC Countries
- 5.6.5 Egypt
- 5.6.6 South Africa
6 Market Size by Type
- 6.1 Global Vinblastinesulphate (CAS 143-67-9) Breakdown Dada by Type
- 6.2 Global Vinblastinesulphate (CAS 143-67-9) Revenue by Type
- 6.3 Vinblastinesulphate (CAS 143-67-9) Price by Type
7 Market Size by Application
- 7.1 Overview
- 7.2 Global Vinblastinesulphate (CAS 143-67-9) Breakdown Dada by Application
- 7.2.1 Global Vinblastinesulphate (CAS 143-67-9) Consumption by Application
- 7.2.2 Global Vinblastinesulphate (CAS 143-67-9) Consumption Market Share by Application (2014-2019)
8 Manufacturers Profiles
- 8.1 Guangzhou Hanfang Pharmaceutical
- 8.1.1 Guangzhou Hanfang Pharmaceutical Company Details
- 8.1.2 Company Description
- 8.1.3 Capacity, Production and Value of Vinblastinesulphate (CAS 143-67-9)
- 8.1.4 Vinblastinesulphate (CAS 143-67-9) Product Description
- 8.1.5 SWOT Analysis
- 8.2 Hainan Vinca Biological Medicine Technology
- 8.2.1 Hainan Vinca Biological Medicine Technology Company Details
- 8.2.2 Company Description
- 8.2.3 Capacity, Production and Value of Vinblastinesulphate (CAS 143-67-9)
- 8.2.4 Vinblastinesulphate (CAS 143-67-9) Product Description
- 8.2.5 SWOT Analysis
- 8.3 Guangzhou Person Pharmaceutical
- 8.3.1 Guangzhou Person Pharmaceutical Company Details
- 8.3.2 Company Description
- 8.3.3 Capacity, Production and Value of Vinblastinesulphate (CAS 143-67-9)
- 8.3.4 Vinblastinesulphate (CAS 143-67-9) Product Description
- 8.3.5 SWOT Analysis
- 8.4 Hainan Yueyang Biotechnology
- 8.4.1 Hainan Yueyang Biotechnology Company Details
- 8.4.2 Company Description
- 8.4.3 Capacity, Production and Value of Vinblastinesulphate (CAS 143-67-9)
- 8.4.4 Vinblastinesulphate (CAS 143-67-9) Product Description
- 8.4.5 SWOT Analysis
- 8.5 Hubei Honch Pharmaceutical
- 8.5.1 Hubei Honch Pharmaceutical Company Details
- 8.5.2 Company Description
- 8.5.3 Capacity, Production and Value of Vinblastinesulphate (CAS 143-67-9)
- 8.5.4 Vinblastinesulphate (CAS 143-67-9) Product Description
- 8.5.5 SWOT Analysis
- 8.6 Fine Chemicals Corporation
- 8.6.1 Fine Chemicals Corporation Company Details
- 8.6.2 Company Description
- 8.6.3 Capacity, Production and Value of Vinblastinesulphate (CAS 143-67-9)
- 8.6.4 Vinblastinesulphate (CAS 143-67-9) Product Description
- 8.6.5 SWOT Analysis
- 8.7 Hengtengfu Biological Products
- 8.7.1 Hengtengfu Biological Products Company Details
- 8.7.2 Company Description
- 8.7.3 Capacity, Production and Value of Vinblastinesulphate (CAS 143-67-9)
- 8.7.4 Vinblastinesulphate (CAS 143-67-9) Product Description
- 8.7.5 SWOT Analysis
- 8.8 Vinkem
- 8.8.1 Vinkem Company Details
- 8.8.2 Company Description
- 8.8.3 Capacity, Production and Value of Vinblastinesulphate (CAS 143-67-9)
- 8.8.4 Vinblastinesulphate (CAS 143-67-9) Product Description
- 8.8.5 SWOT Analysis
9 Production Forecasts
- 9.1 Vinblastinesulphate (CAS 143-67-9) Production and Revenue Forecast
- 9.1.1 Global Vinblastinesulphate (CAS 143-67-9) Production Forecast 2019-2025
- 9.1.2 Global Vinblastinesulphate (CAS 143-67-9) Revenue Forecast 2019-2025
- 9.2 Vinblastinesulphate (CAS 143-67-9) Production and Revenue Forecast by Regions
- 9.2.1 Global Vinblastinesulphate (CAS 143-67-9) Revenue Forecast by Regions
- 9.2.2 Global Vinblastinesulphate (CAS 143-67-9) Production Forecast by Regions
- 9.3 Vinblastinesulphate (CAS 143-67-9) Key Producers Forecast
- 9.3.1 United States
- 9.3.2 Europe
- 9.3.3 China
- 9.3.4 Japan
- 9.4 Forecast by Type
- 9.4.1 Global Vinblastinesulphate (CAS 143-67-9) Production Forecast by Type
- 9.4.2 Global Vinblastinesulphate (CAS 143-67-9) Revenue Forecast by Type
10 Consumption Forecast
- 10.1 Consumption Forecast by Application
- 10.2 Vinblastinesulphate (CAS 143-67-9) Consumption Forecast by Regions
- 10.3 North America Market Consumption Forecast
- 10.3.1 North America Vinblastinesulphate (CAS 143-67-9) Consumption Forecast by Countries 2019-2025
- 10.3.2 United States
- 10.3.3 Canada
- 10.3.4 Mexico
- 10.4 Europe Market Consumption Forecast
- 10.4.1 Europe Vinblastinesulphate (CAS 143-67-9) Consumption Forecast by Countries 2019-2025
- 10.4.2 Germany
- 10.4.3 France
- 10.4.4 UK
- 10.4.5 Italy
- 10.4.6 Russia
- 10.5 Asia Pacific Market Consumption Forecast
- 10.5.1 Asia Pacific Vinblastinesulphate (CAS 143-67-9) Consumption Forecast by Countries 2019-2025
- 10.5.2 China
- 10.5.3 Japan
- 10.5.4 Korea
- 10.5.5 India
- 10.5.6 Australia
- 10.5.7 Indonesia
- 10.5.8 Thailand
- 10.5.9 Malaysia
- 10.5.10 Philippines
- 10.5.11 Vietnam
- 10.6 Central & South America Market Consumption Forecast
- 10.6.1 Central & South America Vinblastinesulphate (CAS 143-67-9) Consumption Forecast by Country 2019-2025
- 10.6.2 Brazil
- 10.7 Middle East and Africa Market Consumption Forecast
- 10.7.1 Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Consumption Forecast by Countries 2019-2025
- 10.7.2 Middle East and Africa
- 10.7.3 Turkey
- 10.7.4 GCC Countries
- 10.7.5 Egypt
- 10.7.6 South Africa
11 Upstream, Industry Chain and Downstream Customers Analysis
- 11.1 Analysis of Vinblastinesulphate (CAS 143-67-9) Upstream Market
- 11.1.1 Vinblastinesulphate (CAS 143-67-9) Key Raw Material
- 11.1.2 Typical Suppliers of Key Vinblastinesulphate (CAS 143-67-9) Raw Material
- 11.1.3 Vinblastinesulphate (CAS 143-67-9) Raw Material Market Concentration Rate
- 11.2 Vinblastinesulphate (CAS 143-67-9) Industry Chain Analysis
- 11.3 Marketing & Distribution
- 11.4 Vinblastinesulphate (CAS 143-67-9) Distributors
- 11.5 Vinblastinesulphate (CAS 143-67-9) Customers
12 Opportunities & Challenges, Threat and Affecting Factors
- 12.1 Market Opportunities
- 12.2 Market Challenges
- 12.3 Porter's Five Forces Analysis
13 Key Findings
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.2 Data Source
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Vinblastinesulphate (CAS 143-67-9) . Industry analysis & Market Report on Vinblastinesulphate (CAS 143-67-9) is a syndicated market report, published as Global Vinblastinesulphate (CAS 143-67-9) Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Vinblastinesulphate (CAS 143-67-9) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
